JMP Securities
http://www.jmpsecurities.com/index.htmlJMP Securities provides investment banking services, institutional brokerage, and equity research to public and private growth companies. Equity research is the backbone of the firm and the industries the firm covers are: Business Services, Financial Services, Real Estate, Consumer, Healthcare, and Technology. The firm is headquartered in San Francisco, CA and is a subsidiary of JMP Group (NYSE: JMP).
View Older Stories View More Recent Stories
-
Entelo Recognized on JMP Securities Hot 100 List of Top Privately Held Software Companies
-
AdCare Health (ADK) Terminates CEO and Chairman for Misrepresenting Educational Credentials
-
JMP Securities Starts Alteryx (AYX) at Market Outperform
-
JMP Group Announces Appointment of Gavin Slader as Head of Mergers and Acquisitions
-
Axovant Sciences Ltd. Announces Closing of Public Offering and Exercise in Full of the Underwriters' Option to Purchase Additional Common Shares
-
JMP Securities Downgrades OncoMed Pharmaceuticals (OMED) to Market Perform
-
Forestar Group (FOR) Acquired by Starwood Capital Group for $605M
-
Forestar Group Inc. to Be Acquired by Starwood Capital Group
-
Upside Case Suggests Mindbody (MB) Could Double in Two Years Amid Google Deal - JMP
-
Ernst & Young Announces Big Switch Networks' Douglas Murray and Kyle Forster as EY Entrepreneur Of The Year 2017 Northern California Semifinalists
-
WAVE Life Sciences (WVE) Prices 4.17M Offering at $24/Ordinary Share
-
WAVE Life Sciences Prices Public Offering of 4,166,667 Ordinary Shares
-
PlacementTracker Publishes Q1 2017 Private Placement Market League Tables
-
Hovnanian Enterprises (HOV) PT Lowered to $1.30 at JMP Securities
-
Axovant Sciences (AXON) Prices 6.74M Shares at $18.54
-
Axovant Sciences Ltd. Announces Pricing of $125M Public Offering of Common Shares
-
JMP Securities Reiterates Market Outperform and $27 PT on K2M Group (KTWO) Following Supply Deal with Australian Distributor
-
Okta (OKTA) IPO Opens 39% Higher
-
JMP Securities Resumes Hospitality Properties Trust (HPT) at Market Perform
-
JMP Securities Resumes Host Hotels (HST) at Market Perform
-
JMP Securities resumes Ashford Hospitality Prime (AHP) at Market Perform
-
Okta (OKTA) IPO Prices at $17, Top End of Range
-
Okta Announces Pricing of Initial Public Offering
-
JMP Securities Reiterates Market Outperform and $65 PT on Tableau Software (DATA) Following Subscription Pricing Announcement
-
Houlihan Lokey (HLI) PT Raised to $36 at JMP Securities
-
JMP Securities Upgrades NetApp (NTAP) to Market Perform
-
BioLineRx Closes $28.75 Million Underwritten Public Offering of its American Depositary Shares
-
Acuity Brands (AYI) PT Lowered to $155 at JMP Securities
-
JMP Securities Starts iStar Financial (STAR) at Market Perform
-
SteadyMed (STDY) PT Raised to $17 at JMP Securities Amid Patent Win RemoSynch Delay
-
JMP Securities Reiterates Market Outperform Rating and $32 PT on MINDBODY (MB); 'Investors Worried About Competition Can Relax'
-
Novocure (NVCR): Positive PANOVA and INNOVATE Trials - JMP
-
Cloverpop Honored as "Hot 100" Company by JMP Securities
-
First Cash Financial Services (FCFS): Raising PT - JMP
-
Egalet to Participate in Spring Investor Conferences
-
JMP Securities Upgrades Forward Pharma (FWP) to Market Perform
-
JMP Securities Upgrades Meritage Homes (MTH) to Market Outperform
-
Carvana Files Registration Statement for Proposed Initial Public Offering
-
Don't Be Surprised if Boston Scientific (BSX) Buys Neovasc (NVCN)- JMP
-
BioLineRx (BLRX) Prices 29.4M Offering at $0.85/ADS
-
BioLineRx Prices $25 Million Underwritten Public Offering
-
JMP Securities Starts Colony NorthStar (CLNS) at Market Perform
-
BioLineRx (BLRX) to Offer ADSs
-
BioLineRx Announces Underwritten Public Offering of its American Depositary Shares
-
Corbus Pharmaceuticals (CRBP) PT Raised to $27 at JMP Securities
-
JMP Securities Downgrades Five Oaks Investment (OAKS) to Market Perform
-
Amazon Connect Not Seen as a Threat to Twilio (TWLO) - JMP
-
Cloudian Named by JMP Securities in 'Super 60' Hot Companies List
-
JMP Securities Reiterates Market Outperform on Aerie Pharma (AERI)
-
JMP Reiterates Market Outperform Rating and $45 PT on AnaptysBio (ANAB); Dupixent Approval Positive for ANB020

